Guggenheim Capital LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 65,455 shares of ARWR stock, worth $1.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

65,455

Previous 60,563 8.08%

Holding current value

$1.28 Million

Previous $1.57 Million 19.5%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$19.36 - $29.54 $94,709 - $144,509	4,892 Added 8.08%	65,455 $1.27 Million
Q2 2024 Aug 14, 2024	SELL	$21.87 - $28.24 $1.2 Million - $1.55 Million	-54,942 Reduced 47.57%	60,563 $1.57 Million
Q1 2024 May 14, 2024	BUY	$27.21 - $39.48 $1.59 Million - $2.31 Million	58,513 Added 102.67%	115,505 $3.3 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $348,379 - $509,915	16,433 Added 40.52%	56,992 $1.74 Million
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $20,645 - $28,431	788 Added 1.98%	40,559 $1.09 Million
Q2 2023 Aug 11, 2023	SELL	$25.16 - $41.38 $181,202 - $298,018	-7,202 Reduced 15.33%	39,771 $1.42 Million
Q1 2023 May 10, 2023	SELL	$23.68 - $38.51 $3,078 - $5,006	-130 Reduced 0.28%	46,973 $1.19 Million
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $29,624 - $42,912	-1,058 Reduced 2.2%	47,103 $1.91 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $254,877 - $415,562	-8,602 Reduced 15.15%	48,161 $1.59 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $7,586 - $13,816	-273 Reduced 0.48%	56,763 $2 Million
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $249,883 - $441,300	6,307 Added 12.43%	57,036 $2.62 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $95,499 - $135,646	-1,644 Reduced 3.14%	50,729 $3.36 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $230,717 - $335,761	3,952 Added 8.16%	52,373 $3.27 Million
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $332,129 - $482,670	-5,344 Reduced 9.94%	48,421 $4.01 Million
Q1 2021 May 13, 2021	BUY	$61.35 - $90.47 $150,430 - $221,832	2,452 Added 4.78%	53,765 $3.57 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $1.67 Million - $3.25 Million	-38,108 Reduced 42.62%	51,313 $3.94 Million
Q3 2020 Nov 13, 2020	SELL	$33.21 - $51.27 $513,592 - $792,890	-15,465 Reduced 14.74%	89,421 $3.85 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $781,353 - $1.29 Million	29,914 Added 39.9%	104,886 $4.53 Million
Q1 2020 Jun 02, 2020	SELL	$20.56 - $63.12 $168,221 - $516,447	-8,182 Reduced 9.84%	74,972 $2.16 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $2.09 Million - $5.43 Million	74,376 Added 847.3%	83,154 $5.27 Million
Q3 2019 Nov 14, 2019	BUY	$26.26 - $34.86 $14,863 - $19,730	566 Added 6.89%	8,778 $247,000
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $143,135 - $236,669	8,212 New	8,212 $218,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Arrowhead Pharmaceuticals, Inc. Transaction History